Comorbidity as a Major Risk Factor for Mortality and Complications in Head and Neck Surgery

This publication has 9 references indexed in Scilit:

• The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
  Published by Elsevier ,2004
• Published by American Medical Association (AMA) ,2002
• Applicability of the adult comorbidity evaluation – 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study
  The Journal of Laryngology & Otology, 2002
• Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Benchmarks for Mortality, Morbidity, and Length of Stay for Head and Neck Surgical Procedures
  JAMA Otolaryngology–Head & Neck Surgery, 2001
• Importance of Comorbidity in Head and Neck Cancer
  The Laryngoscope, 2000
• A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
  Radiotherapy and Oncology, 1998
• Identifying High-Risk Patients Before Head and Neck Oncologic Surgery
  JAMA Otolaryngology–Head & Neck Surgery, 1993
• A multivariate study of the prognosis of oral squamous cell carcinomas. Are blood group and hemoglobin new prognostic factors?
  Cancer, 1991